Egr-1 antisense oligonucleotides inhibit hypoxia-induced proliferation of pulmonary artery adventitial fibroblasts

Journal of Applied Physiology

Volumn 98, Issue 2, 2005, Pages 732-738

  Banks, Mark F ^a   Gerasimovskaya, Evgenia V ^a   Tucker, Doug A ^a   Frid, Maria G ^a   Carpenter, Todd C ^a   Stenmark, Kurt R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cyclin D; Early growth response 1; Epidermal growth factor receptor; Pulmonary hypertension; Vascular remodeling

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLIN D; EARLY GROWTH RESPONSE FACTOR 1; EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; FIBROBLAST; HYPOXIA; IMMUNOHISTOCHEMISTRY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; REVIEW; VASCULAR DISEASE;

ANIMALS; CATTLE; CELL HYPOXIA; CELL PROLIFERATION; CELLS, CULTURED; ENZYME ACTIVATION; FIBROBLASTS; GENE SILENCING; OLIGONUCLEOTIDES, ANTISENSE; PULMONARY ARTERY; SIGNAL TRANSDUCTION;

EID: 12344254223     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00821.2004     Document Type: Review

References (41)

1. Baron V, Duss S, Rhim J, and Mercola D. Antisense to the early growth response-1 gene (Egr-1) inhibits prostate tumor development in TRAMP mice. Ann NY Acad Sci 1002: 197-216, 2003.
2. Belknap JK, Orton EC, Ensley B, Tucker A, and Stenmark KR. Hypoxia increases bromodeoxyuridine labeling indices in bovine neonatal pulmonary arteries. Am J Respir Cell Mol Biol 16: 366-371, 1997.
3. Carpenter G and Cohen S. Epidermal growth factor. J Biol Chem 265: 7709-7712, 1990.
4. Copland IB, Kavanagh BP, Engelberts D, McKerlie C, Belik J, and Post M. Early changes in lung gene expression due to high tidal volume. Am J Respir Crit Care Med 168: 1051-1059, 2003.
5. Das M, Bouchey DM, Moore MJ, Hopkins DC, Nemenoff RA, and Stenmark KR. Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on G protein-mediated activation of mitogen-activated protein kinases. J Biol Chem 276: 15631-15640, 2001.
6. Das M, Dempsey EC, Bouchey D, Reyland ME, and Stenmark KR. Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts: potential contribution of specific protein kinase C isozymes. Am J Respir Cell Mol Biol 22: 15-25, 2000.
7. Das M, Dempsey EC, Reeves JT, and Stenmark KR. Selective expansion of fibroblast subpopulations from pulmonary artery adventitia in response to hypoxia. Am J Physiol Lung Cell Mol Physiol 282: L976-L986, 2002.
8. Das M, Stenmark KR, and Dempsey EC. Enhanced growth of fetal and neonatal pulmonary artery adventitial fibroblasts is dependent on protein kinase C. Am J Physiol Lung Cell Mol Physiol 269: L660-L667, 1995.
9. Fahmy RG and Khachigian LM. Antisense Egr-1 RNA driven by the CMV promoter is an inhibitor of vascular smooth muscle cell proliferation and regrowth after injury. J Cell Biochem 84: 575-582, 2002.
10. Fahmy RG and Khachigian LM. Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth. Nucleic Acids Res 32: 2281-2285, 2004.
11. Fu M, Zhu X, Zhang J, Liang J, Lin Y, Zhao L, Ehrengruber MU, and Chen YE. Egr-1 target genes in human endothelial cells identified by microarray analysis. Gene 315: 33-41, 2003.
12. Fujita T, Asai T, Andrassy M, Stern DM, Pinsky DJ, Zou YS, Okada M, Naka Y, Schmidt AM, and Yan SE. PKCβ regulates ischemia/reperfusion injury in the lung. J Clin Invest 113: 1615-1623, 2004.
13. Gerasimovskaya EV, Ahmad S, White CW, Jones PL, Carpenter TC, and Stenmark KR. Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth. Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor. J Biol Chem 277: 44638-44650, 2002.
14. Guillemot L, Levy A, Raymondjean M, and Rothhut B. Angiotensin II-induced transcriptional activation of the cyclin D1 gene is mediated by Egr-1 in CHO-AT(1A) cells. J Biol Chem 276: 39394-39403, 2001.
15. Khachigian LM and Collins T. Inducible expression of Egr-1-dependent genes. A paradigm of transcriptional activation in vascular endothelium. Circ Res 81: 457-461, 1997.
16. Khachigian LM, Lindner V, Williams AJ, and Collins T. Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science 271: 1427-1431, 1996.
17. Lowe HC, Chesterman CN, and Khachigian LM. Catalytic antisense DNA molecules targeting Egr-1 inhibit neointima formation following permanent ligation of rat common carotid arteries. Thromb Haemost 87: 134-140, 2002.
18. Nishi H, Nishi KH, and Johnson AC. Early growth response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia. Cancer Res 62: 827-834, 2002.
19. Ohtani K, Egashira K, Usui M, Ishibashi M, Hiasa KI, Zhao Q, Aoki M, Kaneda Y, Morishita R, and Takeshita A. Inhibition of neointimal hyperplasia after balloon injury by cis-element "decoy" of early growth response gene-1 in hypercholesterolemic rabbits. Gene Ther 11: 126-132, 2004.
20. Okada M, Fujita T, Sakaguchi T, Olson KE, Collins T, Stern DM, Van SF, and Pinsky DJ. Extinguishing Egr-1-dependent inflammatory and thrombotic cascades after lung transplantation. FASEB J 15: 2757-2759, 2001.
21. Okada M, Wang CY, Hwang DW, Sakaguchi T, Olson KE, Yoshikawa Y, Minamoto K, Mazer SP, Yan SF, and Pinsky DJ. Transcriptional control of cardiac allograft vasculopathy by early growth response gene-1 (Egr-1). Circ Res 91: 135-142, 2002.
22. Pawlinski R, Pedersen B, Kehrte B, Aird WC, Frank RD, Guha M, and Mackman N. Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model. Blood 101: 3940-3947, 2003.
23. Santiago FS, Atkins DG, and Khachigian LM. Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent. Am J Pathol 155: 897-905, 1999.
24. Santiago FS, Lowe HC, Kavurma MM, Chesterman CN, Baker A, Atkins DG, and Khachigian LM. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med 5: 1264-1269, 1999. [Corrigenda. Nat Med 5: December 1999, p. 1438.]
25. Santiago FS, Lowe HC, Kavurma MM, Chesterman CN, Baker A, Atkins DG, and Khachigian LM. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med 5: 1264-1269, 1999. [Corrigenda. Nat Med 5: December 1999, p. 1438.]
26. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88: 1474-1480, 2000.
27. Semenza GL. Oxygen-regulated transcription factors and their role in pulmonary disease. Respir Res 1: 159-162, 2000.
28. Silverman ES and Collins T. Pathways of Egr-1-mediated gene transcription in vascular biology. Am J Pathol 154: 665-670, 1999.
29. Stenmark KR, Bouchey D, Nemenoff R, Dempsey EC, and Das M. Hypoxia-induced pulmonary vascular remodeling: contribution of the adventitial fibroblasts. Physiol Res 49: 503-517, 2000.
30. Stenmark KR, Fasules J, Hyde DM, Voelkel NF, Henson J, Tucker A, Wilson H, and Reeves JT. Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300 m. J Appl Physiol 62: 821-830, 1987.
31. Stenmark KR, Frid M, Nemenoff R, Dempsey EC, and Das M. Hypoxia induces cell-specific changes in gene expression in vascular wall cells: implications for pulmonary hypertension. Adv Exp Med Biol 474: 231-258, 1999.
32. Stenmark KR, Gerasimovskaya E, Nemenoff RA, and Das M. Hypoxic activation of adventitial fibroblasts: role in vascular remodeling. Chest 122: 326S-334S, 2002.
33. Stenmark KR and Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol 59: 89-144, 1997.
34. Tikhomirov O and Carpenter G. Ligand-induced, p38-dependent apoptosis in cells expressing high levels of epidermal growth factor receptor and ErbB-2. J Biol Chem 279: 12988-12996, 2004.
35. Wada Y, Fujimori M, Suzuki J, Tsukioka K, Ito K, Sawa Y, Morishita R, Kaneda Y, Isobe M, and Amano J. Egr-1 in vascular smooth muscle cell proliferation in response to allo-antigen. J Surg Res 115: 294-302, 2003.
36. Wada Y, Suzuki J, Kawauchi M, Kurabayashi M, Tsukioka K, Zhang T, Endoh M, Takayama K, Nagai R, Takamoto S, Isobe M, and Amano J. Early growth-response factor 1 and basic transcriptional element-binding protein 2 expression in cardiac allografts. J Heart Lung Transplant 20: 590-594, 2001.
37. Wang D, Mayo MW, and Baldwin AS Jr. Basic fibroblast growth factor transcriptional autoregulation requires EGR-1. Oncogene 14: 2291-2299, 1997.
38. Wong DL, Tai TC, Wong-Faull DC, Claycomb R, and Kvetnansky R. Genetic mechanisms for adrenergic control during stress. Ann NY Acad Sci 1018: 387-397, 2004.
39. Van SF, Fugita T, Jeishing L, Okada K, Zou YS, Mackman N, Pinsky DJ, and Stern DM. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 6: 1355-1361, 2000.
40. Van SF, Lu J, Xu L, Zou YS, Tongers J, Kisiel W, Mackman N, Pinsky DJ, and Stern DM. Pulmonary expression of early growth response-1: biphasic time course and effect of oxygen concentration. J Appl Physiol 88: 2303-2309, 2000.
41. Van SF, Lu J, Zou YS, Soh-Won J, Cohen DM, Buttrick PM, Cooper DR, Steinberg SF, Mackman N, Pinsky DJ, and Stern DM. Hypoxia-associated induction of early growth response-1 gene expression. J Biol Chem 274: 15030-15040, 1999.